Nuclear medicine physician Steven Larson consults with endocrinologist R. Michael Tuttle and oncologist Eric Sherman on a case involving radio-targeted therapy for a patient with thyroid cancer.
Memorial Sloan-Kettering is a comprehensive center for the detection and treatment of thyroid cancer. Over the past decade, our team has treated more than 6,000 people with thyroid cancer, one of the most curable types of cancer. Some key features of our approach to diagnosis and treatment include:
Our experts describe recent advances in the treatment of thyroid cancer and research on new therapeutic approaches.
We use a multidisciplinary approach to provide the best possible diagnosis and treatment for patients with thyroid cancer. Our treatment team, consisting of specialists from all disciplines involved in the treatment of thyroid cancer, meets weekly to review all patient cases. This ensures that you will receive the combination of therapies that will best address your individual condition.
Our doctors participate in most national clinical trials, as well as clinical trials initiated at Memorial Sloan-Kettering, to improve the detection and treatment of thyroid cancer. Our doctors also participate regularly in national and international medical meetings to present their research.